World's Best Scientists 2026 revealed!
Award Badge
Immunology
Sweden
2026
Award Badge
Medicine
Sweden
2023

D-Index & Metrics

Immunology

D-Index
132
Citations
67666
World Ranking
218
National Ranking
3

Medicine

D-Index
133
Citations
68700
World Ranking
2214
National Ranking
38

Tomas Olsson publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Tomas Olsson sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 777 publications — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Tomas Olsson D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Tomas Olsson sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 132 D-Index — 96th percentile

96% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Sweden Leader Award
  • 2025 - Research.com Immunology in Sweden Leader Award
  • 2023 - Research.com Medicine in Sweden Leader Award
  • 2022 - Research.com Immunology in Sweden Leader Award

Overview

Tomas Olsson is affiliated with the Karolinska Institute in Sweden. Their research primarily focuses on medical sciences with a significant number of publications in the field of pathology and forensic medicine, as well as immunology, molecular biology, oncology, and genetics.

The scientist has contributed extensively to the study of multiple sclerosis and related neurological diseases. Their main topics of research include multiple sclerosis research studies, polyomavirus and related diseases, T-cell and B-cell immunology, systemic lupus erythematosus research, immunotherapy and immune responses, systemic sclerosis and related diseases, and peripheral neuropathies and disorders.

Olsson has published in various respected venues, including:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Neurology Neurosurgery & Psychiatry
  • European Journal of Neurology
  • Multiple Sclerosis Journal
  • Neurology Neuroimmunology & Neuroinflammation

Frequent collaborators include Ingrid Kockum, Lars Alfredsson, Fredrik Piehl, Jan Hillert, and Anna Karin Hedström.

Selected recent papers by Tomas Olsson include:

  • Accuracy of Tau Positron Emission Tomography as a Prognostic Marker in Preclinical and Prodromal Alzheimer Disease, 2021, JAMA Neurology
  • Confounding effect of blood volume and body mass index on blood neurofilament light chain levels, 2020, Annals of Clinical and Translational Neurology
  • Locus for severity implicates CNS resilience in progression of multiple sclerosis, 2023, Nature
  • Inflammation-related plasma and CSF biomarkers for multiple sclerosis, 2020, Proceedings of the National Academy of Sciences
  • FLT3 stop mutation increases FLT3 ligand level and risk of autoimmune thyroid disease, 2020, Nature

The volume and diversity of their research situate Olsson within multiple intersecting disciplines, including clinical studies of neurodegenerative and autoimmune diseases, with a strong emphasis on understanding disease mechanisms and biomarker identification.

Best Publications

  • Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

    Stephen Sawcer;Garrett Hellenthal;Matti Pirinen;Chris C. A. Spencer

  • Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

    Unknown

  • Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

    Niamh Mullins;Andreas J. Forstner;Andreas J. Forstner;Andreas J. Forstner;Kevin S. O'Connell;Kevin S. O'Connell;Brandon Coombes

  • Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

    Ashley H. Beecham;Nikolaos A. Patsopoulos;Nikolaos A. Patsopoulos;Dionysia K. Xifara;Mary F. Davis

  • Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis

    Tomas Olsson;Lisa F. Barcellos;Lars Alfredsson

  • Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis

    Paul O'Connor;Jerry S Wolinsky;Christian Confavreux;Giancarlo Comi

  • Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions.

    Barbara Kornek;Maria K. Storch;Maria K. Storch;Robert Weissert;Erik Wallstroem

  • Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

    Unknown

  • ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis.

    X. Montalban;R. Gold;A. J. Thompson;S. Otero‐Romero

  • Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice.

    Jean Claude Souberbielle;Jean Jacques Body;Joan M. Lappe;Mario Plebani

  • Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

    Bridel C;van Wieringen Wn;Zetterberg H;Tijms Bm

  • Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial.

    Christian Confavreux;Paul O'Connor;Giancarlo Comi;Mark S. Freedman

  • Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology

    Maria K. Storch;Andreas Stefferl;Uschi Brehm;Robert Weissert

  • Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis

    Frida Lundmark;Kristina Duvefelt;Ellen Iacobaeus;Ingrid Kockum

  • Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis.

    Ivan Jelcic;Faiez Al Nimer;Faiez Al Nimer;Jian Wang;Verena Lentsch

  • Neurofascin as a novel target for autoantibody-mediated axonal injury

    Emily K. Mathey;Tobias Derfuss;Maria K. Storch;Kieran R. Williams

  • Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

    Gustavo Luna;Peter Alping;Joachim Burman;Katharina Fink

  • Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma.

    T Olsson;W W Zhi;B Höjeberg;V Kostulas

  • High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women

    Anna K Hedström;Tomas Olsson;Lars Alfredsson

  • Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.

    Lenka Novakova;Henrik Zetterberg;Peter Sundström;Markus Axelsson

  • MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

    Maria Swanberg;Olle Lidman;Leonid Padyukov;Per Eriksson

  • Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab.

    Martin Gunnarsson;Clas Malmeström;Markus Axelsson;Peter Sundström

Frequent Co-Authors

Ingrid Kockum
Ingrid Kockum Karolinska Institute
Jan Hillert
Jan Hillert Karolinska Institute
Lars Alfredsson
Lars Alfredsson Karolinska Institute
Fredrik Piehl
Fredrik Piehl Karolinska Institute
Mohsen Khademi
Mohsen Khademi Karolinska Institute
Hans Link
Hans Link Karolinska Institute
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Mark S. Freedman
Mark S. Freedman Ottawa Hospital
Lars Klareskog
Lars Klareskog Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their career in immunology or related healthcare fields, exploring specialized online programs can be a great option. Many professionals pursue additional certifications to broaden their scope of practice and increase their earning potential. For example, some seek out the cheapest pmhnp certificate programs to specialize in psychiatric mental health nursing while studying flexibly online.

Salary potential is also a critical factor when considering further education. For instance, many graduates with a Doctor of Nursing Practice (DNP) degree look into how much does a dnp make across different states to evaluate where they might want to practice after completing their degree. This can greatly influence career decisions and geographic flexibility.

For nurses aiming to shift their focus within clinical specialties, programs like the fnp to acnp bridge program online provide a smooth transition from family nurse practitioner to acute care nurse practitioner roles. These pathways are especially useful for those targeting acute care positions related to immunological conditions.

Accelerated routes such as the nurse practitioner accelerated program are designed to fast-track careers and help students enter the workforce sooner while gaining critical expertise. Overall, online degree options combined with clear career pathways can support professionals aiming to excel in immunology and healthcare.

Best Scientists Citing Tomas Olsson

Trending Scientists

Recently Published Articles